Metavasi Capital LP Boosts Stake in Talkspace, Inc. $TALK

Metavasi Capital LP boosted its stake in shares of Talkspace, Inc. (NASDAQ:TALK) by 15.8% during the 2nd quarter, Holdings Channel.com reports. The firm owned 1,318,577 shares of the company’s stock after buying an additional 179,478 shares during the quarter. Talkspace accounts for about 1.5% of Metavasi Capital LP’s holdings, making the stock its 25th largest position. Metavasi Capital LP’s holdings in Talkspace were worth $3,666,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. raised its stake in shares of Talkspace by 6.5% in the first quarter. Vanguard Group Inc. now owns 7,650,330 shares of the company’s stock worth $19,585,000 after buying an additional 469,543 shares during the period. American Century Companies Inc. increased its holdings in Talkspace by 4.7% in the 2nd quarter. American Century Companies Inc. now owns 6,750,434 shares of the company’s stock worth $18,766,000 after acquiring an additional 300,476 shares in the last quarter. Deutsche Bank AG raised its stake in Talkspace by 10.6% during the 1st quarter. Deutsche Bank AG now owns 5,104,995 shares of the company’s stock worth $13,069,000 after acquiring an additional 489,510 shares during the period. AWM Investment Company Inc. lifted its holdings in Talkspace by 3.9% during the first quarter. AWM Investment Company Inc. now owns 3,968,500 shares of the company’s stock valued at $10,159,000 after purchasing an additional 150,000 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Talkspace by 0.8% in the second quarter. Geode Capital Management LLC now owns 3,172,179 shares of the company’s stock worth $8,820,000 after purchasing an additional 25,508 shares during the period. Institutional investors own 57.37% of the company’s stock.

Talkspace Stock Performance

NASDAQ TALK opened at $3.37 on Friday. The company has a market capitalization of $558.27 million, a P/E ratio of 112.37 and a beta of 1.20. Talkspace, Inc. has a one year low of $2.22 and a one year high of $4.36. The stock has a 50 day moving average price of $3.09 and a 200-day moving average price of $2.84.

Talkspace (NASDAQ:TALK) last announced its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, hitting the consensus estimate of $0.02. Talkspace had a net margin of 1.98% and a return on equity of 3.75%. The company had revenue of $59.38 million for the quarter, compared to analysts’ expectations of $57.45 million. As a group, equities analysts predict that Talkspace, Inc. will post 0.08 EPS for the current fiscal year.

Analyst Ratings Changes

TALK has been the subject of a number of analyst reports. Zacks Research raised shares of Talkspace from a “strong sell” rating to a “hold” rating in a research note on Friday, October 31st. Barclays initiated coverage on Talkspace in a research note on Monday. They issued an “equal weight” rating and a $3.50 price target for the company. Canaccord Genuity Group raised their price target on Talkspace from $5.00 to $6.00 and gave the company a “buy” rating in a report on Friday, October 31st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Talkspace in a research report on Monday. Finally, Needham & Company LLC reissued a “buy” rating and issued a $5.00 price target on shares of Talkspace in a report on Tuesday, December 2nd. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $4.83.

Talkspace Company Profile

Talkspace, Inc operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists.